These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 14996477

  • 1. Significance of inducible ventricular flutter/fibrillation in risk stratification in patients with coronary artery disease.
    Matsushita T, Chun S, Liem LB, Friday KJ, Sung RJ.
    Int J Cardiol; 2004 Mar; 94(1):67-71. PubMed ID: 14996477
    [Abstract] [Full Text] [Related]

  • 2. Gender differences in ventricular arrhythmia recurrence in patients with coronary artery disease and implantable cardioverter-defibrillators.
    Lampert R, McPherson CA, Clancy JF, Caulin-Glaser TL, Rosenfeld LE, Batsford WP.
    J Am Coll Cardiol; 2004 Jun 16; 43(12):2293-9. PubMed ID: 15193696
    [Abstract] [Full Text] [Related]

  • 3. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.
    Daubert JP, Zareba W, Hall WJ, Schuger C, Corsello A, Leon AR, Andrews ML, McNitt S, Huang DT, Moss AJ, MADIT II Study Investigators.
    J Am Coll Cardiol; 2006 Jan 03; 47(1):98-107. PubMed ID: 16386671
    [Abstract] [Full Text] [Related]

  • 4. Prospective clinical evaluation and follow-up of a cohort of consecutive VT/VF patients, using a staged-care protocol, including coronary arteriography, programmed electrical stimulation and cardiac surgery.
    Naccarella F, Rolli A, Carboni A, Finardi A, Aurier E, Favaro L, Contini S, Gherli T, Caponi D, Maranga SS, Lepera G, Bartoletti A.
    G Ital Cardiol; 1999 Oct 03; 29(10):1142-56. PubMed ID: 10546124
    [Abstract] [Full Text] [Related]

  • 5. Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia.
    Corrado D, Calkins H, Link MS, Leoni L, Favale S, Bevilacqua M, Basso C, Ward D, Boriani G, Ricci R, Piccini JP, Dalal D, Santini M, Buja G, Iliceto S, Estes NA, Wichter T, McKenna WJ, Thiene G, Marcus FI.
    Circulation; 2010 Sep 21; 122(12):1144-52. PubMed ID: 20823389
    [Abstract] [Full Text] [Related]

  • 6. Predictors of VT/VF-occurrence in ICD patients: results from the PROFIT-Study.
    Klein G, Lissel C, Fuchs AC, Gardiwal A, Oswald H, Desousa M, Pichlmaier AM, Lichtinghagen R, Geerlings H, Lippolt P, Niehaus M, Drexler H, Korte T.
    Europace; 2006 Aug 21; 8(8):618-24. PubMed ID: 16864615
    [Abstract] [Full Text] [Related]

  • 7. Outcome after implantation of cardioverter defibrillator [corrected] in patients with Brugada syndrome: a multicenter Israeli study (ISRABRU).
    Rosso R, Glick A, Glikson M, Wagshal A, Swissa M, Rosenhek S, Shetboun I, Khalamizer V, Fuchs T, Boulos M, Geist M, Strasberg B, Ilan M, Belhassen B, Israeli Working Group on Cardiac Pacing and Electrophysiology.
    Isr Med Assoc J; 2008 Jun 21; 10(6):435-9. PubMed ID: 18669142
    [Abstract] [Full Text] [Related]

  • 8. Prospective study of interleukin-6 and the risk of malignant ventricular tachyarrhythmia in ICD-recipients--a pilot study.
    Streitner F, Kuschyk J, Veltmann C, Brueckmann M, Streitner I, Brade J, Neumaier M, Bertsch T, Schumacher B, Borggrefe M, Wolpert C.
    Cytokine; 2007 Oct 21; 40(1):30-4. PubMed ID: 17851087
    [Abstract] [Full Text] [Related]

  • 9. Prognosis among survivors of primary ventricular fibrillation in the percutaneous coronary intervention era.
    de Jong JS, Marsman RF, Henriques JP, Koch KT, de Winter RJ, Tanck MW, Wilde AA, Dekker LR.
    Am Heart J; 2009 Sep 21; 158(3):467-72. PubMed ID: 19699872
    [Abstract] [Full Text] [Related]

  • 10. Induction of ventricular fibrillation rather than ventricular tachycardia predicts tachyarrhythmia recurrences in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillator for secondary prophylaxis.
    Rolf S, Haverkamp W, Borggrefe M, Breithardt G, Bocker D.
    Europace; 2009 Mar 21; 11(3):289-96. PubMed ID: 19095687
    [Abstract] [Full Text] [Related]

  • 11. Differences in mechanisms and outcomes of syncope in patients with coronary disease or idiopathic left ventricular dysfunction as assessed by electrophysiologic testing.
    Brembilla-Perrot B, Suty-Selton C, Beurrier D, Houriez P, Nippert M, de la Chaise AT, Louis P, Claudon O, Andronache M, Abdelaal A, Sadoul N, Juillière Y.
    J Am Coll Cardiol; 2004 Aug 04; 44(3):594-601. PubMed ID: 15358027
    [Abstract] [Full Text] [Related]

  • 12. Ventricular arrhythmia inducibility predicts subsequent ICD activation in nonischemic cardiomyopathy patients: a DEFINITE substudy.
    Daubert JP, Winters SL, Subacius H, Berger RD, Ellenbogen KA, Taylor SG, Schaechter A, Howard A, Kadish A, Defibrillators In Nonischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators.
    Pacing Clin Electrophysiol; 2009 Jun 04; 32(6):755-61. PubMed ID: 19545338
    [Abstract] [Full Text] [Related]

  • 13. An "aggressive" protocol of programmed ventricular stimulation for selecting post-myocardial infarction patients with a low ejection fraction who may not require implantation of an automatic defibrillator.
    Belhassen B, Ohayon-Tsioni T, Glick A, Viskin S.
    Isr Med Assoc J; 2009 Sep 04; 11(9):520-4, 526, 528. PubMed ID: 19960844
    [Abstract] [Full Text] [Related]

  • 14. Recurrent cardiac events in patients with idiopathic ventricular fibrillation, excluding patients with the Brugada syndrome.
    Champagne J, Geelen P, Philippon F, Brugada P.
    BMC Med; 2005 Jan 01; 3():1. PubMed ID: 15627402
    [Abstract] [Full Text] [Related]

  • 15. Depression as a predictor for appropriate shocks among patients with implantable cardioverter-defibrillators: results from the Triggers of Ventricular Arrhythmias (TOVA) study.
    Whang W, Albert CM, Sears SF, Lampert R, Conti JB, Wang PJ, Singh JP, Ruskin JN, Muller JE, Mittleman MA, TOVA Study Investigators.
    J Am Coll Cardiol; 2005 Apr 05; 45(7):1090-5. PubMed ID: 15808769
    [Abstract] [Full Text] [Related]

  • 16. Electrocautery-induced ventricular tachycardia and fibrillation during device implantation and explantation.
    Lo R, Mitrache A, Quan W, Cohen TJ.
    J Invasive Cardiol; 2007 Jan 05; 19(1):12-5. PubMed ID: 17297178
    [Abstract] [Full Text] [Related]

  • 17. Long-term incidence of malignant ventricular arrhythmia and shock therapy in patients with primary defibrillator implantation does not differ from event rates in patients treated for survived cardiac arrest.
    Backenköhler U, Erdogan A, Steen-Mueller MK, Kuhlmann C, Most A, Schaefer C, Stertmann W, Waas W, Tillmanns H, Waldecker B.
    J Cardiovasc Electrophysiol; 2005 May 05; 16(5):478-82. PubMed ID: 15877617
    [Abstract] [Full Text] [Related]

  • 18. [Positive microvolt T-wave alternans as a marker of ventricular arrhythmia trigering during cardioverter-defibrillator implantation].
    Wierzbowski R, Michałkiewicz D, Cholewa M, Jacewicz K, Gniłka A, Adamus J.
    Pol Merkur Lekarski; 2006 Oct 05; 21(124):310-3. PubMed ID: 17205766
    [Abstract] [Full Text] [Related]

  • 19. Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II).
    Singh JP, Hall WJ, McNitt S, Wang H, Daubert JP, Zareba W, Ruskin JN, Moss AJ, MADIT-II Investigators.
    J Am Coll Cardiol; 2005 Nov 01; 46(9):1712-20. PubMed ID: 16256874
    [Abstract] [Full Text] [Related]

  • 20. Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up.
    Pezawas T, Stix G, Kastner J, Schneider B, Wolzt M, Schmidinger H.
    Int J Cardiol; 2006 Mar 08; 107(3):360-8. PubMed ID: 16503259
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.